Continue with FacebookLooking to list your PhD opportunities? Log in here.
alzheimer PhD Projects, Programmes & Scholarships
We have 63 alzheimer PhD Projects, Programmes & Scholarships
PhD saved successfully
Towards restoring memory dysfunction in prodromal Alzheimer’s Disease.
Project outline. Brains contain billions of specialised cells, called neurons, which are the fundamental building blocks of every circuit in the nervous system. Read more
ERK5 MAPK signalling in Alzheimer’s disease
Research Group:
Pharmacology and Experimental Therapeutics
Neurodegenerative diseases have devastating effects on individuals’ lives and our society, with no effective treatments available. Read more
Can transcranial ultrasound be used to change the course of neurodegenerative disease?
White matter impairments are a major component of various neurodegenerative diseases, including Alzheimer’s disease(1,2). White matter is composed of neuronal axons and their encasing myelin; a lipid-rich material produced by the oligodendroglia. Read more
AI and Machine Learning for the diagnosis and monitoring of Parkinson’s and Alzheimer’s disease
The School has long-standing research collaborations with hospitals and medical centres worldwide developing new approaches to the diagnosis and monitoring of neurological conditions, including Parkinson’s and Alzheimer’s. Read more
Investigating the role of endothelial cells in myelin damage in Alzheimer's diseases using iPSC-derived model
Alzheimer’s disease (AD) affects around 50 million people globally with no cure. Apart from well-known neuronal loss, myelin abnormalities in brain have been recently detected from early stage of AD. Read more
Investigating the role of endothelial cells in myelin damage in Alzheimer's disease using iPSC-derived model
Supervisors. Dr. Dan Ma, Lecturer in Biomedical Sciences, Aston Medical School, Aston University. Dr. Irundika Dias, Lecturer in Biomedical Sciences, Aston Medical School, Aston University. Read more
4 Year PhD with Integrated MSc in Neuroscience: ApoE-ε4 induced blood-brain barrier dysfunction in Alzheimer’s disease
Background. Blood-brain barrier dysfunction in Alzheimer’s Disease (AD). The blood-brain barrier (BBB) is formed by a continuous layer of cerebral endothelial cells held together by tight junction proteins (TJP), which restrict the movement of molecules. Read more
Last chance to apply
Development of a multiplex diagnostic test for Alzheimer’s Disease
Research Group:
Medicine
Alzheimer’s disease (AD) is the most common cause of dementia worldwide. Current tools for monitoring AD pathology include neuroimaging biomarkers using MRI or PET and CSF biomarkers. Read more
Generating a disease model for Alzheimer's Disease in non-human primates
Our lab is interested in understanding and treating a devastating neurodegenerative disorder, Alzheimer’s Disease (AD), in particular aspects relating to develop appropriate disease models for AD. Read more
Neuroinflammation, glial cell dysfunction & neurodegenerative diseases
Neurodegenerative disorders, such as Alzheimer’s disease, are often associated with chronic neuroinflammation and glial cell dysfunction that acts to exacerbate neuronal damage and loss of synapses. Read more
The breakdown of neurovascular coupling in the diseased state specifically Epilepsy and Alzheimer’s disease
Epilepsy is the most common neurological condition in the UK, affecting 1 – 2 % of the population. Epilepsies often involve only a small area of the brain - the epileptic focus – and the abnormal activity can propagate out from there. Read more
3D-Printing of implantable devices for the treatment of chronic conditions
Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more
Determining how synaptic connections are lost in the brain in models of dementia
This project is one of 15 four year PhD Studentships funded by Medical Research Scotland (MRS) (. https://www.medicalresearchscotland.org.uk. Read more
Exploring how Natural Language Processing (NLP) can help with the diagnosis of dementia
Research Group:
Visual Computing
The Alzheimer’s Society acknowledges the COVID-19 pandemic led to a significant decrease in dementia diagnosis rates from 67.6% in February 2020 to 63.5% in June 2020. Read more
Understanding the heterogeneity of pathology in dementia with Lewy bodies to aid the interpretation of biomarkers
The primary pathology of dementia with Lewy bodies (DLB) is alpha-synuclein, however multiple studies have demonstrated that Alzheimer’s disease (AD) related pathologies (tau and beta amyloid) play an important role in disease progression driving spread of pathology and accelerating cognitive decline. Read more